Immunogenicity and protective efficacy of recombinant Campylobacter jejuni flagellum-secreted proteins in mice

Shahida Baqar*, Lisa A. Applebee, Theron C. Gilliland, Lanfong H. Lee, Chad K. Porter, Patricia Guerry

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

29 Scopus citations

Abstract

Immunogenicity and protective efficacy of three Campylobacter jejuni flagellum-secreted proteins, FlaC, FspA1, and FspA2, were compared by use of a mouse model. Mice were immunized intranasaily with each protein with or without LTR192G as the adjuvant and challenged intranasaily with C. jejuni 81-176 or CG8486. All three proteins were immunogenic, although FspA1 induced the highest levels of serum immunoglobulin G (IgG) and fecal IgA. Although immunogenic, FlaC provided only 18% protection against disease from C. jejuni 81-176. Immunization with FspA1 resulted in 57.8% protection without adjuvant or 63.8% protection with adjuvant against homologous challenge with 81-176. Alternatively, immunization with FspA2 provided 38.4% (without adjuvant) or 47.2% (with adjuvant) protection against disease from homologous challenge with CG8486. In contrast to FspA2, FspA1 provided some heterologous protection against C. jejuni CG8486 when delivered with (31.2%) or without (44.8%) LTR192G. These results suggest that FspA1 may be a good subunit vaccine candidate against C. jejuni disease.

Original languageEnglish
Pages (from-to)3170-3175
Number of pages6
JournalInfection and Immunity
Volume76
Issue number7
DOIs
StatePublished - Jul 2008
Externally publishedYes

Fingerprint

Dive into the research topics of 'Immunogenicity and protective efficacy of recombinant Campylobacter jejuni flagellum-secreted proteins in mice'. Together they form a unique fingerprint.

Cite this